about
Positron Emission Tomography in Breast CancerNational consensus in China on diagnosis and treatment of patients with advanced breast cancerMusculoskeletal tumours and tumour-like conditions: common and avoidable pitfalls at imaging in patients with known or suspected cancer: Part B: malignant mimics of benign tumoursAdvances in molecular imaging for breast cancer detection and characterizationRole of Positron Emission Tomography-Computed Tomography in Locally Advanced Breast CancerA Review on Automatic Mammographic Density and Parenchymal SegmentationDiffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.Nuclear imaging of the breast: translating achievements in instrumentation into clinical useTowards non-invasive characterization of breast cancer and cancer metabolism with diffuse optics.Integrating Imaging Data into Predictive Biomathematical and Biophysical Models of CancerFDG PET/CT in carcinoma of unknown primaryRecent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.Can 18F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with 18F-Fluorodeoxyglucose Positron Emission Tomography?A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expressionQuantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1.Molecular Imaging in Breast Cancer - Potential Future Aspects.Positron Emission Mammography Imaging with Low Activity Fluorodeoxyglucose and Novel Utilization in Core-needle Biopsy SamplingThe use of molecular breast imaging to assess response in women undergoing neoadjuvant therapy for breast cancer: a pilot studyBreast conservation in locally advanced breast cancer.Targeting breast cancer with sugar-coated carbon nanotubes.The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patientsOestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FESBioelectrical Impedance Methods for Noninvasive Health Monitoring: A ReviewSpectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT.The vanadyl chelate bis(acetylacetonato)oxovanadium(IV) increases the fractional uptake of 2-(fluorine-18)-2-deoxy-D-glucose by cultured human breast carcinoma cellsTumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective study.Positron emission mammography (PEM): reviewing standardized semiquantitative methodPrognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.Investigating the limit of detectability of a positron emission mammography device: a phantom study.68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients.F-18 fluoro-deoxy-glucose and F-18 sodium fluoride cocktail PET/CT scan in patients with breast cancer having equivocal bone SPECT/CT.Where does radioimmunotherapy fit in the management of breast cancer?Molecular imaging for the characterization of breast tumors.Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.Molecular imaging using PET for breast cancer.Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer.The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review.18F-5-Fluoroaminosuberic Acid as a Potential Tracer to Gauge Oxidative Stress in Breast Cancer Models.Whither the PET scan? The role of PET imaging in the staging and treatment of breast cancer.
P2860
Q26768486-95D423E3-2489-43F5-8175-7BF4E6ED8A31Q26775621-3E28490E-428F-470F-9A8F-10595B789D05Q26865396-1905FC24-04CE-4C6E-82F1-3C17F20F69DDQ27000462-682C9BC2-4032-41F2-B6B1-5A60D54AE467Q28079818-839CB883-0276-482F-BF74-66ABFB673B44Q28081790-0F47A385-E41A-47AF-BEFA-92F7B6108CE4Q28710339-166DA06E-6E2E-4B65-B4FA-7BF777606E8BQ30419180-E0EB86AA-2C53-4006-B0F7-979EF25F3BE9Q30435832-B01F6523-C587-4A5C-92C5-962292F5C933Q30659261-CF2A7263-EC76-4B44-92E3-E30027B5C087Q33654392-F00443BA-ECD5-4CF4-9472-2F2F06D235C8Q33669828-38D5D68A-E6A4-439C-87C1-D938AF50BE56Q33702526-1DE4AD24-4D4E-443C-A3FE-B8222EAC81B9Q34435496-CE302622-2EE5-4070-B908-1D5F2F01F064Q35000636-A37BEE99-61A8-4380-8124-90243A854568Q35016225-E570E99D-8E0D-4610-9D37-7F7CB5D14F72Q35109408-E0582C99-4B7D-4084-BF4C-BF5AAC315849Q35810208-3C84D308-5364-439D-A40C-FC9A21B91093Q36169992-4DE6B5FD-0886-4D96-889F-D23BA755F066Q36175013-2311B14F-78F6-4493-BE96-3C341BC7FE73Q36324071-5F8E5773-D1B6-416E-80DE-9A6C06DB6FE0Q36326057-94D731CD-6CD2-4819-B872-378819069640Q36663345-E60CB853-7784-4C86-8269-D46639A5491EQ36992771-1BC65DA8-3A45-41F9-90AB-E9EB782D1552Q37070763-8EF9D0B5-D7BF-441D-9E1C-CD452DA3D54CQ37212682-E3E946C0-C8AC-41C9-9CA1-BC0E0BCE9757Q37314333-79B87DE0-192D-41F1-9C01-D8A8AF4F7223Q37482604-9B28A511-B687-4D31-BCAF-5F59F42E2655Q37489946-E60FB5CB-C3D9-4A32-9CA2-C1E863C24AA1Q37662685-E7DFA334-E102-4201-B5C4-715BC144A2FDQ37718618-299EFEC1-1786-4945-84A7-66C78BFB60F7Q38125535-B1D5F8CF-AF1B-4012-8BB8-DA6CA9B733CCQ38189444-0FC979A7-99B1-4706-87CB-A840610AB89AQ38205936-1418BEDC-C909-4A5A-8F02-5FE3DC07DEB8Q38444869-8FB7BBC0-320D-4EF9-B1D6-54D9E97A2F2FQ38462434-9E20907C-3223-4D48-80C4-52C6E03EA02FQ38471361-9D175F4B-760A-4753-80A5-C8ACD49A87E0Q38668780-140D121A-1D22-4341-9EC0-48DE72DCAB20Q38735688-3AF5B13E-F3FC-4B5B-B5D2-BA79854E7264Q39685741-81A42B8E-B8C3-497F-9CB8-D65E285CAA2F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FDG PET, PET/CT, and breast cancer imaging.
@en
FDG PET, PET/CT, and breast cancer imaging.
@nl
type
label
FDG PET, PET/CT, and breast cancer imaging.
@en
FDG PET, PET/CT, and breast cancer imaging.
@nl
prefLabel
FDG PET, PET/CT, and breast cancer imaging.
@en
FDG PET, PET/CT, and breast cancer imaging.
@nl
P2093
P356
P1433
P1476
FDG PET, PET/CT, and breast cancer imaging.
@en
P2093
David A Mankoff
Eric L Rosen
William B Eubank
P304
P356
10.1148/RG.27SI075517
P478
27 Suppl 1
P577
2007-10-01T00:00:00Z